rickster... you raise good questions. I'm becoming concerned with their cash burn, their cash position (I think is < than 10M), and their 320M O/S and float. I'm 98% sure that Michael Frank executed a R/S in a previous position somewhere (I can't locate that link now). Have you done any DD on the risk of an R/S with RVVTF? They have no real revenues, and the bills are piling up fast with the FDA trial.